---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/272547432.md"
description: "PR: At this stage, the direct revenue from the company's DiOrion platform drug development services accounts for a small proportion of the company's overall operating income, which does not have a significant impact on the company's overall operating situation"
datetime: "2026-01-14T11:57:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272547432.md)
  - [en](https://longbridge.com/en/news/272547432.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272547432.md)
---

# 

PR: At this stage, the direct revenue from the company's DiOrion platform drug development services accounts for a small proportion of the company's overall operating income, which does not have a significant impact on the company's overall operating situation

### Related Stocks

- [301230.CN](https://longbridge.com/en/quote/301230.CN.md)

## Related News & Research

- [10:01 ETIn Vitro Toxicology Testing Market worth $20.97 billion by 2031 | MarketsandMarkets™](https://longbridge.com/en/news/289608726.md)
- [13:15 ETInventHelp Inventor Develops New Billiard Training Tool (TLS-1356)](https://longbridge.com/en/news/289625387.md)
- [5,000 S’porean children receive $10k grant and other benefits under scheme to spur large families](https://longbridge.com/en/news/289284060.md)
- [22:31 ETLive the Final: BC.GAME Offers Players the Chance to Win 2026 Football Final Tickets](https://longbridge.com/en/news/289262470.md)
- [12:36 ETAra: History Untold v2.1 Update Adds National Crafting Policy System, Now Available](https://longbridge.com/en/news/289622479.md)